Edit This Favorite

Rivanna Commences Manufacturing of Its Accuro Device

Rivanna Medical has begun manufacturing its FDA-cleared Accuro™ device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San Diego, Oct. 24-28, 2015.

The Accuro™ device is designed to provide automated 3D navigation to an anatomical target so a clinician may avoid “guessing” where the target is. The initial commercial application of RIVANNA’s Accuro™ platform is designed for guiding clinicians to a first-attempt success in administering spinal anesthesia into the epidural space.

“There are numerous clinical uses for Accuro™, which is designed to be a disruptive, game-changing platform technology,” said John A. Williams, President and CEO. “The Accuro™ platform, based on automated 3D navigation, has an addressable $1+ billion U.S. market today. Because of the considerable unmet clinical need for automated image guidance in general, and in the spinal anesthesia market especially, we are looking forward to launching Accuro™ at the upcoming annual scientific meeting of the ASA.”